GLP-1 drugs currently being tested in China target complications associated with obesity such as heart disease, fatty liver ...

You've heard about the likes of Ozempic, Wegovy and Mounjaro, jabs which a growing number of people are taking in an attempt ...

Doctors are seeing an increase in hair loss among Ozempic users due to the stress of rapid weight loss. The condition is ...

SHOPPING: If you're tired of struggling to lose weight, you may just need a little help - and Hers makes it simpler than ever ...

Migraines are a common ailment worldwide, affecting nearly 15% of the global population. At times, they can be debilitating enough to interfere with daily activities. Despite a multitude of treatment ...

A drug that can be taken orally could soon rival the likes of Ozempic for treating type 2 diabetes and obesity, according to ...

The MHRA has revealed it's received more than 560 reports of acute pancreatitis in patients taking GLP-1 injections since ...

Already a household name in diabetes and weight management, Ozempic (semaglutide) may soon find another surprising role — as ...

WEIGHT loss, warding off dementia, ‘curing’ diabetes and now… anti-ageing powers? Is there anything the so-called fat jabs can’t do? While a medicine that reverses the clock would be a ...

The UK's medicines regulator has launched a study to investigate the impact of these drugs following reports of people dying ...

Both semaglutide and tirzepatide for type 2 diabetes and weight loss are GLP-1 agonists, meaning they mimic the hormone.

From 1 July, the weight-loss drug Wegovy will become available from Belgian pharmacists on prescription. This means Wegovy is ...